Table 2.
Variable | HC | HT | GD | Normal range |
---|---|---|---|---|
No. | 30 | 36 | 30 | – |
Age (years) | 37 ± 8 | 34 ± 9 | 30 ± 9 | – |
Gender (M/F) | 4/26 | 4/32 | 5/25 | – |
Thyrotropin (mIU/L) | 1.3 ± 0.2 | 14.2 ± 3.16 | 0.007 ± 0.01 | 0.35–4.94 |
FT4 (ng/dL) | 1.4 ± 0.1 | 0.9 ± 0.2 | 46.02 ± 14.7 | 9.01–19.05 |
FT3 (pg/mL) | 2.6 ± 0.5 | 3.7 ± 0.2 | 34.3 ± 6.9 | 2.63–5.70 |
Thyrotrophin receptor antibody (IU/L) | – | – | 37.6 ± 9.5 | 0–1 |
TPOAb (IU/mL) | 5.03 ± 0.7 | 343.27 ± 126.2 | 167.5 ± 23.2 | 0.11–5.23 |
TgAb (IU/mL) | 2.54 ± 0.5 | 433.45 ± 102.7 | 192.28 ± 17.32 | 0.81–3.83 |
Data are expressed as mean ± SD. The “–” represents that the experiment was not performed, or the data are not applicable.
M, male; F, female; HT, Hashimoto’s thyroiditis; GD, Graves’ disease; HC, healthy controls.